Skip to main content
. Author manuscript; available in PMC: 2023 Jul 15.
Published in final edited form as: AIDS. 2022 Jun 21;36(9):1233–1243. doi: 10.1097/QAD.0000000000003234

Figure 1. Estimation of the minimum adherence level needed to produce HIV VL suppression in 90% of tests overall (A) and by ART regimen type (B), among 837 PHLIV-PWUD in Vancouver, Canada, 1996–2017.

Figure 1.

*PDC, proportion of days covered; INSTI, integrase inhibitor; NNRTI, nonnucleoside reverse transcriptase inhibitor; PI, protease inhibitor. The horizontal lines represent the 90% benchmark for viral suppression and the dotted vertical lines represent the PDC level at which 90% of HIV VL measures were suppressed (HIV-1 RNA <200 copies/mL).